credentis – Persistence of Product Innovation

Publications

3. September 2018

Swiss university trial confirms superiority of CURODONT™ REPAIR in treatment of initial caries lesions

A randomized, placebo and gold-standard controlled clinical trial (RCT), investigating the treatment of incipient buccal caries lesions with CURODONT™ REPAIR was presented at the IADR 2018 in London. In this study Prof. Krejci and his team at the University of Geneva showed that the use of CURODONT™ REPAIR is superior to that of fluoride varnish … read more

23. August 2018

Additional 15 years of IP protection for CURODONT™ REPAIR

Innovation is in our DNA! While credentis goes new ways to prevent and treat caries, it is strong in the development of innovative medical devices and cosmetic solutions for the professional oral care market. An additional patent for a “Method for producing a composition for treating a tooth lesion” has now been granted  in the … read more

22. May 2018

Dentin hypersensitivity: CURODONT™ D’SENZ shows faster desensitization than sensitivity toothpaste

In their study “Self-Assembling Peptide Matrix for treatment of dentin hypersensitivity: A randomized controlled clinical trial», Dr. M. Schlee and colleagues compared the ability of the CURODONT™ D’SENZ gel and a professional desensitizing toothpaste containing 8% arginine and calcium carbonate [ACC] to alleviate dentin hypersensitivity (DHS) over a period of 90 days.